Stories
- Abrocitinib Induction, Randomized Withdrawal, and Retreatment In Patients with Moderate-to-Severe Atopic Dermatitis (AD) ‒ JADE REGIMEN
Clinical trial 
- Efficacy and Safety of Abrocitinib Versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis – JADE DARE
Clinical trial 
- Ritlecitinib in Alopecia Areata: ALLEGRO 2b/3 Pivotal Phase 3 Clinical Trial
Clinical trial 
- Long Term Efficacy and Safety from the ALLEGRO Clinical Trial Program
Clinical trial 